Perhaps you have already succumbed to the temptation of ethnic DNA analyzes. You do a small smear on the cheek and, by paying around seventy francs, you send it to a company which will tell you that 5% of your blood is Dutch, Ukrainian, even Scandinavian.
To know the Swiss component in Moderna’s DNA, I won’t even need to resort to this kind of practice. A videoconference will suffice to understand the central role that Switzerland has played in the development of the American start-up that has changed the course of the pandemic. It is the company’s communications officer who will deliver the information to me. Comfortably installed in his office, on the other side of my screen and an ocean, Ray Jordan announces to me that according to the estimates of Moderna, at the present time, “about 25% of the shares of the start- up are in Swiss hands. “
–
–
